2-Chlorobenzothiazole

The synthesis of N-cyclohexyl-2-benzothiazole sulfenamide (CBS) via oxidative coupling of cyclohexylamine and 2-chlorobenzothiazole (CBT) remains the largest single volume application, consuming approximately 55–65% of all commercial CBT output according to aggregated process economics data from elastomer chemistry supply chains. During synthesis, the molar feed ratio of CBT to cyclohexylamine is maintained at 1:1.02–1:1.08 to drive the nucleophilic displacement toward completion while suppressing secondary amine bis-adduct formation; the free cyclohexylamine content in the final CBS product must remain below 0.5 wt% as specified in ISO 11235:2016 Clause 4.2, otherwise accelerated amine bloom and metallic corrosion of tire cord adhesion systems are documented at loadings exceeding 1.2 phr in typical NR/BR carcass compounds. A jacketed glass-lined oxidation reactor equipped with a 3-stage pitched-blade turbine agitator operating at 120–150 rpm is charged with pre-cooled cyclohexylamine solution, and CBT dissolved in toluene is metered over 45–60 min while maintaining the internal temperature at 30–35°C and pH at 9.5±0.5 using 12–15% sodium hypochlorite solution as the oxidant. Temperature excursions above 38°C during the coupling step are known from full-scale batch records at a 6-tonne daily capacity installation to produce elevated levels of dicyclohexylamine salt and the symmetrical disulfide 2,2′-dithiobis(benzothiazole) (MBTS), which reduces CBS purity below the 96% threshold required for tire tread compounds and shortens the Mooney scorch time (t5 at 127°C) by 15–20% when tested per ASTM D5289-19a. Post-reaction, the organic phase is separated, washed with deionized water until conductivity drops below 50 µS/cm, and concentrated via a wiped-film evaporator at 85–90°C under 5–10 kPa vacuum to recover toluene, followed by a final finishing step through a 2 µm sintered metal filter to remove insoluble oligomers. The dried CBS powder or granular form (bulk density 0.55–0.70 g/cm³) is the direct terminal product shipped to tire manufacturers for silica-reinforced passenger car tire treads and engineered rubber goods under REACH registration 01-2119524078-41 and with ongoing analytical verification against Chinese GB/T 8829-2013 method of free amine titration.

What drives the selectivity of CBT in mefenacet synthesis towards the O-aryl intermediate over N-alkyl byproducts?

The herbicidal active ingredient mefenacet, 2-(1,3-benzothiazol-2-yloxy)-N-methylacetanilide, is assembled through the phase-transfer catalyzed condensation of CBT with N-methyl-2-hydroxyacetanilide in a ketone or aprotic polar solvent milieu, and the control of O- vs. N-alkylation selectivity dictates the economic viability of the entire batch. A typical manufacturing recipe charges CBT and the hydroxyacetanilide at a molar ratio of 1:1.03–1:1.06 in dimethylformamide (8–10 volumes relative to CBT mass) with anhydrous potassium carbonate (1.2 molar equivalents) as the acid scavenger and 0.3–0.5 mol% tetrabutylammonium bromide; the mixture is heated to 78–82°C and aged for 6–8 hours under a nitrogen blanket to prevent oxidative darkening. Any residual moisture in the system exceeding 500 ppm leads to competitive hydrolysis of the 2-chloro substituent, generating 2-hydroxybenzothiazole, which co-crystallizes with the target product and depresses the active ingredient content below the 95% w/w minimum required by FAO Specification 504/TC/S/F (draft 1994) and subsequent Chinese ministerial standard NY/T 3578-2020. After neutralization of the carbonate with 10% hydrochloric acid at 5–10°C, the crude mefenacet is precipitated by drowning into chilled water, centrifuged through a peeler centrifuge with a basket diameter of 1250 mm at 950 rpm, and dried in a double-cone rotary vacuum dryer at 60–65°C to a final moisture of ≤0.5%. The terminal product is mefenacet technical concentrate (TC) that is further formulated into 50% wettable powder or 16% suspension concentrate for rice paddy weed management, and compliance with European Union Regulation EC 1107/2009 requires a comprehensive five-batch analysis of the impurity profile, including the quantification of residual CBT and 2-hydroxybenzothiazole at levels not exceeding 1.0 g/kg and 0.5 g/kg respectively.

Heterocyclic disperse dyes for polyester coloration are produced using the 2-chloro group of CBT as the electrophilic anchor in nucleophilic aromatic substitution reactions with para-nitroaniline or substituted anilines, yielding precursors that undergo diazotization and coupling to dialkylaniline coupling components. The synthesis sequence loads CBT and 4-nitroaniline in a 1:0.96–1:0.98 molar ratio into N-methyl-2-pyrrolidone (5 volumes) with potassium fluoride (1.5 equivalents) and a catalytic amount of 18-crown-6; the mixture is refluxed at 195–200°C for 12–14 hours under rigorous exclusion of atmospheric moisture, as water ingress above 200 ppm hydrolyzes the chloride and terminates the chain. The isolated 2-(4-nitroanilino)benzothiazole intermediate is reduced with iron powder in aqueous acetic acid at 95°C, the resulting amine is diazotized with sodium nitrite at 0–5°C in the presence of concentrated hydrochloric acid, and the diazonium salt is coupled to N,N-diethyl-m-toluidine at pH 4.0–4.5 maintained with sodium acetate buffer. The resulting monoazo disperse dye exhibits a λmax in acetone of 530–540 nm and a molar extinction coefficient exceeding 45,000 L·mol⁻¹·cm⁻¹, suitable for high-energy dyeing of polyester fibers at 130°C under pressure. Commercial finishing via spray drying after diafiltration to remove sodium chloride yields a granular dye with particle size distribution D50 of 1.5–2.5 µm and D90 below 5 µm, which is critical to prevent speck formation during package dyeing of texturized yarns. The produced dyestuff falls under the scope of OEKO-TEX Standard 100 Annex 4 limit values for aryl amines releasable from azo cleavage (≤20 mg/kg per method EN 14362-1:2024), and it must be listed in the ZDHC MRSL Version 3.1 as chemically compliant, with documentation that no chlorinated solvents or o-phenylphenol were used during synthesis—a mandatory requirement for brands sourcing through the Bluesign system.

Pharmacophore Building Block: 2-Chlorobenzothiazole in Kinase Inhibitor Scaffolds and Alkylthio-linked Bioconjugates

In early-phase pharmaceutical development, the chlorine atom of CBT undergoes palladium-catalyzed cross-coupling or direct nucleophilic displacement to install benzothiazole cores into small-molecule libraries targeting tyrosine kinases and serine/threonine kinases, with a particular recent focus on irreversible covalent inhibitors of mutant epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK). The typical medicinal chemistry route charges CBT (1.0 equivalent) and a substituted piperidine or piperazine (1.1–1.3 equivalents) in acetonitrile or 2-butanol in the presence of triethylamine (2.0 equivalents) under reflux for 16–24 hours, after which the crude 2-amino-substituted benzothiazole is purified by flash chromatography on silica gel with 4–7% methanol in dichloromethane; the isolated yield typically ranges from 55–72% depending on the steric bulk of the incoming amine nucleophile, with the principal process impurity being the hydrolyzed derivative 2-hydroxybenzothiazole, which is removed by a bicarbonate wash during workup. A process scaled to 500 L pilot-plant equipment at a contract manufacturing organization operating under ICH Q7 Section 7.3 and 21 CFR 211.67 cleaning validation protocols has demonstrated that residual CBT in the final isolate must be controlled below 0.15% as measured by HPLC at a quantitation limit of 0.05% to comply with ICH M7(R2) mutagenic impurity classification (Class 2 by primary aromatic amine structural alert screening with DEREK Nexus 6.3). The immediate downstream product is commonly the free base or hydrochloride salt of a benzothiazole-substituted intermediate that is then further elaborated into a drug candidate; the final dosage form is typically an immediate-release tablet or capsule for oral administration, requiring full characterization of the crystal form by XRPD and DSC to satisfy FDA 21 CFR 314.50(d) upon eventual IND filing. Environmental release of CBT-containing aqueous streams from the synthesis is managed through 0.01-µm ultrafiltration and activated carbon polishing to maintain total organic carbon below 10 mg/L, in accordance with the pharmaceutical wastewater guidelines aligned with EU Directive 2010/75/EU for best available techniques.

When Alkaline Hydrolysis of CBT Opened the Mercaptan Route to 2-Mercaptobenzothiazole (MBT) for Critical Antioxidant Protection

Though large-scale MBT production currently favors the classic aniline–carbon disulfide–sulfur high-pressure cyclization, the hydrolysis of CBT with sodium hydrosulfide or a polysulfide mixture remains a strategically relevant alternative route when captive CBT inventory requires direct conversion to the free thiol without isolation of intermediate bis-thiazole disulfides, especially in integrated rubber chemical plants where MBT is immediately further processed into zinc salt (ZMBT) antioxidants or into 2,2′-dibenzothiazyl disulfide (MBTS) for natural rubber latex preservation. In this sequence, CBT is reacted with an aqueous solution of NaSH (2.05–2.15 molar equivalents) at 105–115°C and 0.15–0.25 MPa gauge pressure in a 316L stainless steel autoclave fitted with a rupture disc rated at 0.50 MPa, with vigorous agitation supplied by a magnetic drive impeller at 350 rpm to disperse the organic phase. The hydrolysis conversion exceeds 98% within 4 hours, and the resulting sodium mercaptide solution is oxidized by air sparging at 0.3 Nm³/h per kilogram of MBT theoretical yield in the presence of 0.05–0.1 wt% activated carbon to precipitate the dimeric disulfide MBTS; careful control of the airflow must avoid overoxidation to benzothiazole sulfonic acid, which, if present above 0.8 wt% in MBT, drastically reduces the scorch delay in sulfur-cured NR formulations measured according to ISO 1306:1995 (MBT, technical grade). The final product is either isolated as free-running MBT powder with melting point 178–182°C and ash content ≤0.3% or, more commonly, neutralized in situ with zinc sulfate to produce a ZMBT slurry that is spray-dried into a free-flowing powder used at 0.5–2.0 phr in wire skim compounds for radial tires, where its dual function as secondary accelerator and antioxidant protects against copper-catalyzed degradation at the brass-plated steel cord interface. All formulations containing MBT or its derivatives must comply with the German TRGS 615 occupational exposure limits for benzothiazole-2-thiol (BAT value 25 µg/g creatinine in urine) and with the labeling requirements of EU Directive 1272/2008/EC, Annex VI, for skin sensitization category 1 (H317).